PubMed:26253900 / 13-128
Annnotations
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 4-9 | GO:0007568 | denotes | aging |
| T5 | 17-31 | D004198 | denotes | susceptibility |
| T6 | 17-31 | D004198 | denotes | susceptibility |
| T8 | 35-45 | GO:0000502 | denotes | proteasome |
| T7 | 35-45 | GO:0004299 | denotes | proteasome |
| T9 | 35-55 | D061988 | denotes | proteasome inhibitor |
| T10 | 35-55 | D061988 | denotes | proteasome inhibitor |
| T11 | 35-55 | CHEBI:52726 | denotes | proteasome inhibitor |
| T13 | 95-114 | UBERON:0027239 | denotes | dopaminergic system |
UseCases_ArguminSci_Discourse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 0-115 | DRI_Background | denotes | and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system. |